Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 17Breast Neoplasms 17Prostatic Neoplasms 10Hematologic Neoplasms 9Colorectal Neoplasms 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 6Hematopoietic and Lymphatic System Neoplasm 5Urinary Bladder Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Head and Neck Neoplasms 4Anatomic Stage I Breast Cancer AJCC v8 4Triple Negative Breast Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Mouth Neoplasms 3Melanoma 3Malignant Solid Neoplasm 3Leukemia, Myeloid, Acute 3Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Parotid Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Head and Neck Carcinoma 2Glioma 2Carcinoma, Squamous Cell 2Carcinoma, Renal Cell 2Carcinoma, Basal Cell 2COVID-19 2

Interventions

testosterone 17 beta-cypionate 1pembrolizumab 1enfortumab vedotin 1Testosterone Propionate 1Standard of Care 1Radiation Dose Hypofractionation 1Practice Guidelines as Topic 1Mitomycin 1Methyltestosterone 1Gemcitabine 1Fluorouracil 1Cisplatin 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Diseases × Standard of Care × 90 days × Clear all
NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Emory University

Phase 1 Active not recruiting
56 enrolled
Genitourinary

Hypogonadism, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡